The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia

E-ISSN： 1097-0215|137|11|2729-2738

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.11, 2015-12, pp. : 2729-2738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy in acute myeloid leukemia

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Variation in Human Leukocyte Antigen and Susceptibility to Acute Myeloid Leukemia

Acta Haematologica, Vol. 133, Iss. 2, 2014-09 ,pp. : 162-163

Karger

Access to resources Recommend Favorite

Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 279-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chimeric antigen receptor T-cell neuropsychiatric toxicity in acute lymphoblastic leukemia

Palliative & Supportive Care, Vol. 15, Iss. 4, 2017-01 ,pp. : 499-503

Cambridge University Press

Access to resources Recommend Favorite

Development of Transgenic Rice Expressing Mite Antigen for a New Concept of Immunotherapy

International Archives of Allergy and Immunology, Vol. 149, Iss. 1, 2009-06 ,pp. : 21-24

Karger

Access to resources Recommend Favorite